D-0289-2015 Class III Terminated
FDA drug recall D-0289-2015 was initiated by Zydus Pharmaceuticals USA Inc on Sep 24, 2014 and is designated Class III. Reason for recall: Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules. The recall status is terminated (terminated Jun 21, 2017). Affected quantity: 63,648 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 10, 2014
- Initiation Date
- Sep 24, 2014
- Termination Date
- Jun 21, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 63,648 Bottles
Product description
BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01
Reason for recall
Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.
Distribution pattern
US Nationwide including Puerto Rico
Code information
Lot #: MM8555, Expiry: 09/14; Lot #: MM6604, Expiry: 09/14; Lot #: MM8551, Expiry: 09/14; Lot #: MM8552, Expiry: 09/14; Lot #: MM8553, Expiry: 09/14; Lot #: MM8554, Expiry: 09/14.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0289-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026